1 / 17

Case Presentation-Dermatology

Case Presentation-Dermatology. Kevin T. Belasco, MSIV Touro Univ. College of Osteopathic Medicine May 24, 2004. Case Presentation. 32 y/o Caucasian female presents to community clinic with a chief complaint of fever, rash, malaise, and arthralgia with sudden onset beginning 4 days ago

leia
Download Presentation

Case Presentation-Dermatology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case Presentation-Dermatology Kevin T. Belasco, MSIV Touro Univ. College of Osteopathic Medicine May 24, 2004

  2. Case Presentation • 32 y/o Caucasian female presents to community clinic with a chief complaint of fever, rash, malaise, and arthralgia with sudden onset beginning 4 days ago • HPI: Patient returned 6 days ago from a three month-long church mission to Cambodia, where she taught English. She states her diet was composed largely of chicken and rice, with coconut milk and purified bottled water.

  3. Case Presentation (Cont.) • HPI (Cont.)Patient states she developed a cough with yellow sputum 3 weeks ago and was treated with a tetracycline antibiotic. She denies any headache, dizzines, chills, night sweats, N/V, diarrhea, or hematuria. She also denies any sick contacts • PMHx/PSHx: Tonsillectomy 1982, Cholecystectomy 1991. PMHx otherwise non-contributory • Allergies: NKDA • Meds: MVI, Tylenol prn muscle aches • SocHx: Denies smoking, EtOH, or illicit drug use. Lives with boyfriend in Los Angeles; schoolteacher

  4. Case Presentation (Cont.) • ROS: as per HPI; fever, rash, arthralgia, and malaise • VS: T 100.9, P 95 R 22 BP 133/84 • PE: Systems normal except described below: • Gen: WD/WN, pleasant female, NAD, AAO x 3 • HEENT: NC/AT, EOMI, no conjunctival injection, no pharyngeal erythema or exudate, no oral lesions • Skin: sharply demarcated, painful plaques with erythema and pustules on the upper trunk, neck, and face • Musculoskeletal: Mild erythema and swelling with tenderness to palpation over left elbow joint

  5. Case Presentation (Cont.) • Laboratory values: • CBC: 16/14.0/40/343 N74 L20 M3 E1 B0 • BMP: 136/4.1/105/28/16/1.1/112 • ESR: 40 • PPD: negative

  6. Differential Diagnosis Erythema multiformeDrug Eruption, Fixed Cellulitis Pyoderma gangrenosum Granuloma annulare/ facialeErythema nodosumBehçet's disease

  7. Differential Diagnosis Sweet’s SyndromeSjögren’s SyndromeRheumatoid Arthritis (Cutaneous nodules)Systemic Lupus Erythematosus Cutaneous Tuberculosis (Lupus vulgaris) Erythema induratum Subcorneal pustular dermatosis Erythema elevatum et diutinum Leukocytoclastic vasculitis

  8. Summary of Findings • Clinical: Painful plaques with pustules with abrupt onset fever and arthralgia; history of recent international travel; recent upper respiratory tract infection • Labs: • Leukocytosis with neutrophilia and lymphopenia • Elevated ESR • Negative Gram stain

  9. Sweet’s syndrome • Acute febrile neutrophilic dermatosis • Initially described in 1964 by Robert Sweet • Three types: 1. Classic (Strep., Yersinia, BCG/Pneumococcal vaccine, IBD, pregnancy, idiopathic) 2. Malignancy-associated (AML) 3. Drug-induced (G-CSF, all-trans retinoic acid, minocycline, Bactrim, OCPs, carbamazepine, hydralazine) • female-to-male ratio of 2-3:1 • several hundred cases have been reported in the literature

  10. Sweet’s syndrome • Typically, skin lesions are preceded by URI or GI infection, and only occur after a 1-3 week asymptomatic period • Most common in women over 30 • Up to 20% cases associated with malignancy

  11. Sweet’s syndrome Tender, well-demarcated erythematous plaques George Wash. Univ. Dermatology Dept

  12. Sweet’s syndrome Pseudovesiculation with pustules and soft elevation in the center- mamillated George Wash. Univ. Dermatology Dept

  13. Sweet’s syndrome • Painful erythematous plaques with pustulation www.dermis.net

  14. Sweet’s syndrome: Histopathology www.dermis.net

  15. Sweet’s syndrome: Histopathology • Skin biopsy reveals dermal neutrophilic infiltrate in reticular dermis with leukocytoclasia (fragmentation of neutrophilic nuclei); epidermis is usually spared • Associated clinical phenomena: Koebnerization Pathergy (skin lesions at site of trauma)

  16. Sweet’s syndrome: Treatment • Prednisone is rapidly effective, in doses ranging from 40-80 mg/day (initial dose of 0.5-1.5 mg per kg per day) • Topical and intralesional corticosteroids have frequently been used as adjunctive treatment along with systemic modalities • Indomethacin, cyclosporine, dapsone, colchicine, KI, doxycycline, and clofazamine have been reported in the literature as effective alternative treatment modalities

  17. References • Habif: Clinical Dermatology, 4th ed., Mosby 2004 • Odom, et al: Andrew’s Diseases of the Skin, 9th ed., Elsevier 2000 • Fitzpatrick, JE: Dermatology Secrets in Color. Hanley & Belfus 2001 • www.emedicine.com (Kimball AB review article) • www.dermis.net • dermatology.cdlib.org (Dermatology Online Journal)

More Related